drugset / Trial / NCT07108777

L-Carnitine Protective Effect in Nephrotoxicity

NCT07108777

Phase 2 Recruiting 46 enrolled Tanta University
RandomizedParallel-groupDouble-blindPrevention

Summary

The goal of this clinical trial is to assess the possible reno-protective effect of L-carnitine against cisplatin-induced nephrotoxicity in patients receiving cisplatin-based chemotherapy. The main question it aims to answer is: Does L-carnitine have the ability to protect the kidney against cisplatin-induced nephrotoxicity?

Timeline

Start
2025-08-10
Primary completion
2026-08-01
Completion
2026-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator L-carnitine Other / unclassified 350 mg Oral

Indications